Nature Medicine study shows Peregrine's bavituximab can cure lethal virus ... (ral infection of cells. Our data go a s...)

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

Date:11/23/2008

ral infection of cells. Our data go a step further, providing compelling evidence that exposed PS itself is a promising anti-viral drug target that is involved in the pathogenesis of multiple viruses, suggesting the possibility of achieving broad-spectrum anti-viral effects using a single anti-PS agent. We look forward to further exploring the potential of bavituximab and other anti-PS antibodies against viruses for which there are few or no effective therapeutic options."

In the first study, 100% of mice infected with lethal murine CMV and treated with bavituximab recovered fully, while only 25% of control animals survived. In the second study, guinea pigs were infected with lethal Pichinde virus, which is a model virus for Lassa fever. Fifty percent of the bavituximab-treated group survived, while untreated animals all died. In this study, the anti-viral effect of bavituximab was further augmented by the addition of the standard of care drug ribavirin, with 63% of animals receiving the combination therapy surviving the potentially lethal infection.

"We are extremely pleased to see this research demonstrating the broad anti-viral potential of bavituximab and our anti-PS technology platform published in this highly regarded journal," said Steven W. King, president and CEO of Peregrine. "This new publication is the latest in a series of external validations of our anti-viral program. It follows a recently awarded federal government contract for assessment of anti-PS antibodies to treat viral hemorrhagic fevers, research on the role of PS in viral infections that was published in a leading science journal earlier this year, and a recent presentation on anti-PS antibodies at a global HIV conference."

Mr. King added, "Better prevention and treatment of viral diseases are urgently needed, and we are increasingly optimistic that bavituximab and our other anti-PS antibodies could be valuable contributors to the field."

PS i
'/>"/>

Contact: Barbara Lindheim
blindheim@biocompartners.com
212-918-4650
BioCom Partners
Source:Eurekalert

3

GOOD

Page: 1 2 3
Related biology news :

1. Nature study demonstrates that bacterial clotting depends on clustering
2. Extreme nature helps scientists design nano materials
3. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
4. Cancer signatures uncovered
5. Nature publishes new evidence about the deep biosphere written by biogeoscientists
6. Dartmouth researchers discover gene signatures for scleroderma
7. Scattered nature of Wisconsins woodlands could complicate forests response to climate change
8. Giving nature a helping hand
9. A molecular switch turns on the flame in natures blowtorch
10. Male seahorses are natures Mr. Mom, Texas A&M researchers say
11. Nature paper describes technique for extracting hierarchical structure of networks

Post Your Comments:

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus ...(ral infection of cells. Our data go a s...)